Inflammatory bowel diseases: where we are and where we should go

被引：6
作者：
Tonutti, Elio [2 ]
Agostinis, Paolo [3 ]
Bizzaro, Nicola [1 ]
机构：
[1] Osped San Antonio, Lab Patol Clin, I-33028 Tolmezzo, Italy
[2] Azienda Osped Univ S Maria della Misericordia, Immunopatol & Allergol Clin, Udine, Italy
[3] Osped San Antonio, Unita Med Interna, Serv Gastroenterol, I-33028 Tolmezzo, Italy
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2014年 / 52卷 / 04期
关键词：
ANTIBODIES;
D O I：
10.1515/cclm-2014-0146
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：463 / 465
页数：3
相关论文
共 50 条
  • [31] New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
    Basu, Biswanath
    Angeletti, Andrea
    Islam, Bilkish
    Ghiggeri, Gian Marco
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] How to and should we target EBV in MS?
    Eckert, Svetlana
    Jakimovski, Dejan
    Zivadinov, Robert
    Hicar, Mark
    Weinstock-Guttman, Bianca
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (07) : 703 - 714
  • [33] Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
    Misra, Anisha
    Theel, Elitza S.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (06)
  • [34] Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases
    Padoan, Andrea
    Musso, Giulia
    Contran, Nicole
    Basso, Daniela
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (07) : 5534 - 5557
  • [35] A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?
    Perwein, Maria K.
    Smestad, John A.
    Warrington, Arthur E.
    Heider, Robin M.
    Kaczor, Mark W.
    Maher, Louis J., III
    Wootla, Bharath
    Kunbaz, Ahmad
    Rodriguez, Moses
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (05) : 545 - 560
  • [36] Chronic inflammatory bowel diseases: Which choice for the autoantibodies?
    Chauveau, A.
    Delaperriere, N.
    Cholet, F.
    Binard, A.
    Youinou, P.
    Renaudineau, Y.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2009, 24 (01): : 24 - 31
  • [37] Molecular Endoscopy and in vivo Imaging in Inflammatory Bowel Diseases
    Neurath, Markus F.
    DIGESTIVE DISEASES, 2015, 33 : 32 - 36
  • [38] Pharmacokinetics of Infliximab and Reduction of Treatment for Inflammatory Bowel Diseases
    Williet, Nicolas
    Paul, Stephane
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (04) : 990 - 995
  • [39] How should we proceed with the standardization in case of allergen determination?
    Lacorn, M.
    Weiss, T.
    Immer, U.
    ACCREDITATION AND QUALITY ASSURANCE, 2013, 18 (02) : 119 - 125
  • [40] How should we proceed with the standardization in case of allergen determination?
    M. Lacorn
    T. Weiss
    U. Immer
    Accreditation and Quality Assurance, 2013, 18 : 119 - 125
12345